How common is primary aldosteronism?
- PMID: 33660617
- DOI: 10.1097/MNH.0000000000000702
How common is primary aldosteronism?
Abstract
Purpose of review: Primary aldosteronism, characterized by renin-independent aldosterone secretion from one or both adrenal glands, is the most common and modifiable form of secondary hypertension. The prevalence of primary aldosteronism is increasingly recognized to be much higher than previously thought with many cases still undetected.
Recent findings: Prior prevalence studies on primary aldosteronism have reported a wide range of estimates due to heterogeneity of both disease definitions and study populations such that it is difficult to claim a single point estimate. More recent evidence demonstrates that primary aldosteronism, as defined by conventional biochemical diagnostic criteria, is highly prevalent within populations where it is not typically considered such as mild-to-moderate hypertension, prehypertension, and even normotension. Yet, our current screening approach fails to capture many cases. Furthermore, there is mounting evidence that renin-independent aldosteronism exists as a continuum of disease that extends below the current biochemical diagnostic thresholds used to define primary aldosteronsim and has clinically relevant treatment and outcome implications for a much broader patient population. Indeed, much of what we current label as 'essential hypertension' is, in fact, renin-independent aldosterone-mediated hypertension.
Summary: Primary aldosteronism and milder forms of renin-independent aldosteronism are highly prevalent, yet vastly under-recognized, in the general population.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.Ann Intern Med. 2020 Jul 7;173(1):10-20. doi: 10.7326/M20-0065. Epub 2020 May 26. Ann Intern Med. 2020. PMID: 32449886 Free PMC article.
-
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.J Clin Endocrinol Metab. 2020 Dec 1;105(12):3771-83. doi: 10.1210/clinem/dgaa606. J Clin Endocrinol Metab. 2020. PMID: 32865201 Free PMC article. Review.
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
-
Primary aldosteronism: A common and curable form of hypertension.Cardiol Rev. 1999 Jul-Aug;7(4):207-14. Cardiol Rev. 1999. PMID: 10423672 Review.
-
Continuum of Renin-Independent Aldosteronism in Normotension.Hypertension. 2017 May;69(5):950-956. doi: 10.1161/HYPERTENSIONAHA.116.08952. Epub 2017 Mar 13. Hypertension. 2017. PMID: 28289182 Free PMC article.
Cited by
-
What We Know about and What Is New in Primary Aldosteronism.Int J Mol Sci. 2024 Jan 11;25(2):900. doi: 10.3390/ijms25020900. Int J Mol Sci. 2024. PMID: 38255973 Free PMC article. Review.
-
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism.Front Endocrinol (Lausanne). 2023 Mar 6;14:1061704. doi: 10.3389/fendo.2023.1061704. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36950676 Free PMC article. Review.
-
Primary aldosteronism - a multidimensional syndrome.Nat Rev Endocrinol. 2022 Nov;18(11):665-682. doi: 10.1038/s41574-022-00730-2. Epub 2022 Aug 31. Nat Rev Endocrinol. 2022. PMID: 36045149 Review.
-
Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism.Am J Hypertens. 2022 Jun 16;35(6):561-571. doi: 10.1093/ajh/hpab189. Am J Hypertens. 2022. PMID: 34883509 Free PMC article.
-
Heart-Ankle Pulse Wave Velocity Is Superior to Brachial-Ankle Pulse Wave Velocity in Detecting Aldosterone-Induced Arterial Stiffness.Biomedicines. 2021 Sep 22;9(10):1285. doi: 10.3390/biomedicines9101285. Biomedicines. 2021. PMID: 34680402 Free PMC article.
References
-
- Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168:80–85.
-
- Hundemer GL, Curhan GC, Yozamp N, et al. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol 2018; 3:768–774.
-
- Hundemer GL, Curhan GC, Yozamp N, et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 2018; 6:51–59.
-
- Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45:1243–1248.
-
- Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 2017; 69:1811–1820.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
